KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $11.03 $12.67 Friday, 26th Apr 2024 DVAX stock ended at $11.21. This is 0.358% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.09% from a day low at $11.03 to a day high of $11.26.
90 days $11.03 $13.41
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Feb 15, 2023 $11.29 $11.46 $11.19 $11.45 807 201
Feb 14, 2023 $11.23 $11.41 $11.08 $11.34 1 072 864
Feb 13, 2023 $11.05 $11.33 $10.98 $11.27 942 768
Feb 10, 2023 $11.02 $11.15 $10.93 $11.05 1 078 819
Feb 09, 2023 $11.31 $11.39 $10.93 $11.00 930 843
Feb 08, 2023 $11.46 $11.56 $11.21 $11.22 1 059 125
Feb 07, 2023 $11.55 $11.64 $11.23 $11.59 1 302 388
Feb 06, 2023 $11.61 $11.64 $11.34 $11.63 1 379 160
Feb 03, 2023 $11.64 $12.02 $11.64 $11.69 1 476 917
Feb 02, 2023 $11.53 $11.93 $11.49 $11.88 1 705 014
Feb 01, 2023 $11.30 $11.54 $11.05 $11.40 1 331 425
Jan 31, 2023 $11.40 $11.56 $11.23 $11.38 1 197 679
Jan 30, 2023 $11.74 $11.74 $11.22 $11.41 1 191 459
Jan 27, 2023 $11.81 $12.00 $11.71 $11.84 1 034 859
Jan 26, 2023 $11.90 $11.93 $11.51 $11.78 1 846 282
Jan 25, 2023 $11.55 $11.82 $11.42 $11.81 769 660
Jan 24, 2023 $11.50 $11.72 $11.49 $11.68 889 658
Jan 23, 2023 $11.35 $11.59 $11.30 $11.58 1 110 300
Jan 20, 2023 $11.31 $11.35 $11.06 $11.30 1 946 189
Jan 19, 2023 $11.13 $11.30 $11.04 $11.15 918 641
Jan 18, 2023 $11.35 $11.68 $11.16 $11.17 1 214 100
Jan 17, 2023 $11.30 $11.37 $11.13 $11.35 1 145 574
Jan 13, 2023 $11.13 $11.57 $11.06 $11.35 1 198 282
Jan 12, 2023 $10.97 $11.44 $10.77 $11.42 1 526 230
Jan 11, 2023 $10.64 $11.06 $10.49 $10.96 1 544 546
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT